As a core we've performed several tests with epicentre's Nextera DNA Sample Prep and compared to our current Illumina preps. We are noticing very rigid coverage lines and significant bias in our reads with Nextera. I was looking forward to the short prep but the bias is not acceptable. I'm guessing it's the enzymatic cutting that's causing this. Enzymes have some design behind them that physical fragmentation doesn't have. Just wanted to put this out there for people not aware of the bias. Comments from other people's experience would be great.
-
-
The data we have seen indicate Nextera libraries are comparable to those made using other mechanical/enzymatic fragmentation systems. This includes full-coverage libraries from human, bacteria, Drosophila, soy, viruses, PCR amplicons, cDNA, and a variety of plasmid DNAs. Some of our collaborators have submitted a manuscript directly comparing Nextera libraries to those made by mechanical and enzymatic fragmentation methods, wherein they characterized insertion bias, library complexity, genome coverage distribution, GC bias, and other library metrics. These data will also be presented at the CHI XGen Congress in March 2011.
In general, all systems have bias resulting from many contributing factors. For example, standard mechanical fragmentation library preps have bias resulting from the ligation step. Downstream emPCR or bPCR steps contribute to GC coverage bias as well.
Can you provide any specific information regarding the bias you are observing? This would be very helpful in troubleshooting. -
Nextera bias
If the DNA template is limited in quantity, could the bias in the Nextera output in some libraries be due to PCR amplification, even with only the recommended 9 cycles of amplification?Last edited by Boonie; 04-08-2011, 07:21 AM.Comment
-
Yes, PCR can be a significant contributor to bias (in all methods of library prep). See Adey et al. doi:10.1186/gb-2010-11-12-r119Comment
-
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing... -
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...09-01-2026, 05:41 AM
Comment